These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5598902)

  • 21. [On the mechanism of the effect of various inhibitors of fibrinolysis].
    Donner L; Housková J
    Sb Lek; 1967; 69(11):343-51. PubMed ID: 5299789
    [No Abstract]   [Full Text] [Related]  

  • 22. On the action mechanism of some fibrinolysis inhibitors.
    Donner L; Housková J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the effect of fibrinolysin inhibitors on the degranulation grade of basophilic granulocytes].
    Frick G; Frick U
    Z Gesamte Inn Med; 1968 Jun; 23(11):321-5. PubMed ID: 5304218
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heparin-adrenaline complex as a humoral agent of the anticoagulation system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1971; 17(1):46-53. PubMed ID: 5555145
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of fibrinolysis inhibitors on tissue changes produced by hexadimethrinbromide].
    Szijj I; Kovács K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):487-95. PubMed ID: 4184475
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of combined administration of EACA and heparin on thrombus weight and fibrinolysis. An experimental study.
    Komatsu K; Hayakawa D; Suzuki K; Tomita S; Fukushima Y
    Bull Tokyo Med Dent Univ; 1973 Mar; 20(1):93-104. PubMed ID: 4515656
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
    Coombey D; Tyler HM
    Thromb Diath Haemorrh; 1972 Apr; 27(2):241-5. PubMed ID: 5049613
    [No Abstract]   [Full Text] [Related]  

  • 28. [Localized fibrinolysis of the tonsil and antiplasmin compounds].
    Asaga M; Okamoto M; Asaga H; Kimura M
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):462-3. PubMed ID: 5106660
    [No Abstract]   [Full Text] [Related]  

  • 29. [The action of fibrinolysis inhibitors of the omega-aminocarboxylic acid type on the proliferation of in vitro cultured endothelial cells].
    Pilgrim H
    Pharmazie; 1986 Jul; 41(7):519-20. PubMed ID: 3490674
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 31. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the anticoagulant effect of some inhibitors of fibrinolysis].
    Donner L; Housková J
    Sb Lek; 1969 Apr; 71(4):85-91. PubMed ID: 5305357
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of epsilon-amino-caproic acid, acetyl-epsilon-amino-caproic acid and trasylol on allergic reactions induced by dinitrochlorobenzen in guinea pigs.
    Onisk Z; Tchórzewski H
    Pol Med J; 1968; 7(1):190-5. PubMed ID: 5300915
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibitors of fibrinolysis. (Our experience with epsilon-aminocaproic acid and the Kunitz inhibitor)].
    Babío San Salvador JL; Iriarte Ezcurdia JA; Ezcurra Cebreiro JM
    Rev Clin Esp; 1965 Nov; 99(4):249-52. PubMed ID: 5863279
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antifibrinolytic and toxic properties of 5-aminocaproic acid under experimental conditions].
    Zaĭtseva RI
    Farmakol Toksikol; 1965; 28(2):196-9. PubMed ID: 5849201
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of experimental arterial spasm caused by subarachnoid hemorrhage by use of an antifibrinolytic agent].
    Fortuna A; La Torre E
    Riv Neurol; 1970; 40(6):424-36. PubMed ID: 5519838
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of omega-aminoacids on the activation of the first component of complement at low ionic strength.
    Takada Y; Takada A
    Thromb Haemost; 1981 Feb; 45(1):86-9. PubMed ID: 6787729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on the pathogenetic mechanisms of hemorrhages due to induced venous stasis. II. Role of fibrinolysis in the pathogenesis of the hemorrhagic phenomenon due to stasis].
    Neri Serneri GG; Rossi Ferrini PL; Franchi F; Paoletti P
    Haematologica; 1965; 50(4):251-66. PubMed ID: 4953556
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrinolytic bleedings in urology].
    Lipsky H; Hubmer O
    Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.